 Connection
Erin Schenk to Receptors, Antigen, T-Cell
This is a "connection" page, showing publications Erin Schenk has written about Receptors, Antigen, T-Cell.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.186 |
|
|
|
-
Sweis RF, Melero I, Davar D, Garralda E, Hamid O, Chen HA, Evans TRJ, Moore KN, Sacco JJ, Thistlethwaite F, Williams A, Blumenschein GR, Callahan MK, Johnson ML, Schenk EL, Wustner J, Stanhope S, Tao K, Marshall S, Lopez J. Phase 1/2 study of IMC-C103C, a T cell receptor bispecific (MAGE-A4×CD3) ImmTAC targeting MAGE-A4-expressing malignancies. J Immunother Cancer. 2026 Jul 20; 14(7).
Score: 0.186
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|